Back

Use of anti-arrhythmic drug therapy following cryoballoon ablation of paroxysmal atrial fibrillation does not lead to improved clinical outcome. Data from a multicenter observational project.

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Atrial fibrillation ablation Rhythm Control, Catheter Ablation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Maurizio Landolina

Maggiore Hospital of Crema, Crema (Italy)

29 More presentations in this session

Presentation thumbnail
Terminating the induced atrial tachyarrhythmia after complete pulmonary vein isolation during catheter ablation for persistent atrial fibrillation
Professor Y. Oh (Seoul, KR)
Abstract Slides
Presentation thumbnail
How long the duration of atrial fibrillation is associated with poor rhythm outcome after catheter ablation?
Associate Professor H. Yu (Seoul, KR)
Abstract
Presentation thumbnail
Comparison of the efficacy of new-generation atrial antitachycardia pacing between patients with sick sinus syndrome and atrioventricular block
Doctor S. Otuki (Osaka, JP)
Abstract
Presentation thumbnail
Figure-of-eight stitch access site closure significantly reduces bleeding complications in patients undergoing cryoballoon ablation guided by intracardiac echocardiography
Doctor V. Rubesch-Kuetemeyer (Detmold, DE)
Abstract Slides
Presentation thumbnail
Cryoballoon ablation of atrial fibrillation guided by high-resolution mapping: a multicentre study
Professor G. Conte (Lugano, CH)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Atrial fibrillation ablation

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources